Bifunctional chimera that coordinately targets human immunodeficiency virus 1 envelope gp120 and the host-cell CCR5 coreceptor at the virus–cell interface.
Rashad, A. A.; Song, L.-R.; Holmes, A. P.;Long, Y.-Q.* and Chaiken, I.*
J. Med. Chem.2018, 61, 5020–5033.(IF=6.253)
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy.
Qin, L.-H.; Wang, Z.-L.; Xie, X. and Long, Y.-Q.*
Bioorg. Med. Chem.2018, 26 (12), 3559-3572
Bioorthogonal chemistry: Optimization and application updates during 2013–2017.
Qin, L.-H.; Hu, W. and Long, Y.-Q.*
Tetrahedron Lett.2018, 59, 2214-2228.
The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential.
Peng, D.; Cao, B.; Zhou, Y.-J. and Long, Y.-Q.*
Eur. J. Med. Chem.2018, 149, 148-169.